Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
J. Crespo, F. Pons Romero.
Colangitis esclerosante primaria.
Gastroenterol Hepatol, 22 (1999), pp. 290-301
[2.]
K.M. Boberg, A. Spurkland, G. Rocca, T. Egeland, S. Saarinen, S. Mitchell, et al.
The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis.
Scand J Gastroenterol, 36 (2001), pp. 886-890
[3.]
L. Wen, Y. Ma, D.P. Bogdanos, F.S. Wong, A. Demaine, G. Mieli-Vergani, et al.
Pediatric autoimmune liver diseases: the molecular basis of humoral and cellular immunity.
Curr Mol Med, 1 (2001), pp. 379-389
[4.]
B. Terjung, H.J. Worman.
Anti-neutrophil antibodies in primary sclerosing cholangitis.
Best Pract Res Clin Gastroenterol, 15 (2001), pp. 629-642
[5.]
M. Wilschanski, P. Chait, J.A. Wade, L. Davis, M. Corey, P. St Louis, et al.
Primary sclerosing cholangitis in 32 children: clinical, laboratory and radiographic features, with survival analysis.
Hepatology, 22 (1995), pp. 1415-1422
[6.]
K.M. Vitellas, R.A. Enns, M.T. Keogan, K.S. Freed, C.E. Spritzer, J. Baillie, et al.
Comparison of MR cholangiopancreatographic techniques with contrast-enhanced cholangiography in the evaluation of sclerosing cholangitis.
Am J Roentgenol, 178 (2002), pp. 327-334
Copyright © 2002. Elsevier España, S.L.. Todos los derechos reservados
